Concurrent Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.81M Buy
40,332
+4,643
+13% +$794K 0.07% 287
2025
Q4
$6.02M Buy
35,689
+31,766
+810% +$5.16M 0.07% 285
2025
Q3
$566K Sell
3,923
-77
-2% -$10.5K 0.01% 859
2025
Q2
$506K Sell
4,000
-523
-12% -$64.2K 0.01% 842
2025
Q1
$579K Buy
4,523
+375
+9% +$50.8K 0.01% 705
2024
Q4
$548K Buy
4,148
+436
+12% +$61.3K 0.01% 647
2024
Q3
$541K Buy
3,712
+123
+3% +$17.8K 0.02% 600
2024
Q2
$493K Buy
3,589
+630
+21% +$84.1K 0.02% 588
2024
Q1
$406K Sell
2,959
-66
-2% -$9.01K 0.02% 605
2023
Q4
$411K Buy
+3,025
New +$369K 0.02% 543

Other funds holding IBB